Journal Publications

Export 131 results:
Author Title Type [ Year(Asc)]
Filters: Type is Journal Article  [Clear All Filters]
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts. Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte A, Rakhmanova A, Phillips A et al. Antivir Ther, 2007, Volume 12, Issue 3, p.325-33, (2007)
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study. Phillips A, Leen C, Wilson A, Anderson J, Dunn D, Schwenk A, Orkin C, Hill T, Fisher M, Walsh J et al. Lancet, 2007 Dec 08, Volume 370, Issue 9603, p.1923-8, (2007)
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. Phillips A, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti A, Clarke J, Churchill D, Williams I, Hill T et al. AIDS, 2005 Mar 25, Volume 19, Issue 5, p.487-94, (2005)
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study. Smith C, Phillips A, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G et al. J Infect Dis, 2005 Oct 15, Volume 192, Issue 8, p.1387-97, (2005)
Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study. Sabin C, Hill T, Lampe F, Matthias R, Bhagani S, Gilson R, Youle M, Johnson M, Fisher M, Scullard G et al. BMJ, 2005 Mar 26, Volume 330, Issue 7493, p.695, (2005)